Tuesday , December 12 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 8)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

April 15, 2017

This week, the AMA, in their journal, advised that they were in discussions to shift their focus from A1c and glucose readings as an indicator of successful diabetes management to a more cardiovascular outcomes and mortality data measurement of success. I am in total agreement that improving these numbers will …

Read More »

April 11, 2017

I got to the office in Atlanta after a week at home and it looked like the sidewalks have been coated with yellow paint. But it was pollen from all the trees. Evidently the rapid changes in temperature over the past month or so had driven the pollen factor into …

Read More »

April 8, 2017

About 6-7 years ago, Dr. Oz came on TV touting the benefit of reservatrol for weight loss, and overnight sales went through the roof. He had his own brand and pretty soon every nutritional company had their product on the market. Just like every nutritional product, it worked for motivated …

Read More »

April 4, 2017

For years they said there would be a “cure” for diabetes. There was INGAP therapy, beta cell transplants, Dr. Denise Faustman, and many other promising developments that were supposed to be the next big thing in diabetes. However, it seems that now we are looking to manage diabetes rather than …

Read More »

April 1, 2017

One of the biggest methods of improving glucose levels and weight that we recommend is exercise. It seems like a simple solution: be more active, burn more calories, burn more glucose — lose weight and improve A1c’s. However, many of our patients have other complications, and often programs that work for …

Read More »

March 28, 2017

It seems that the do-all, fix-all, be-all for kidney problems is either an ARB or ACE-I. We start patients on these medications at the first sign of elevated glucose levels regardless of their blood pressure levels, as they “protect” the kidneys. This is definitely true, but what do we do …

Read More »

March 25, 2017

Most of the time when we speak about patients who are not diagnosed with diabetes and who develop complications, we are usually referring to vision changes or things like neuropathy. However, it now appears that there are a good number of these undiagnosed who die from ketoacidosis. This week, our …

Read More »

March 21, 2017

There are a lot of great things we can do for our patients to make their lives healthier and more livable. The problem is they all take time to accomplish and our current healthcare system does not allow prescribers enough time to even try to help. That is why nurses, …

Read More »

March 18, 2017

Sometimes you learn things from your interns that you never forget. About eight years ago, I was working with a diabetes patient in a physician’s office. The patient was on three times the normal dose of potassium, but their levels were still low. One of my interns looked at the …

Read More »

March 14, 2017

I recently had a conversation with one of my riding buddies about his A1c. His doctor had recommended he go on metformin because his A1c was 5.9. This guy sometimes rides 700 miles in a week and is thin as a rail. Our conversation got a response from three other …

Read More »